Pyruvic acid - CAS 127-17-3
Catalog: |
BB006739 |
Product Name: |
Pyruvic acid |
CAS: |
127-17-3 |
Synonyms: |
2-oxopropanoic acid |
IUPAC Name: | 2-oxopropanoic acid |
Description: | Pyruvic acid (CAS# 127-17-3) is converted to acetaldehyde and CO2 by carboxylase. In muscle, Pyruvic acid (derived from glycogen) is reduced to lactic acid during exertion, which is reoxidized and partially retransformed to glycogen during rest. The liver can convert Pyruvic acid to alanine by amination. A diagnostic agent for Parkinson disease. |
Molecular Weight: | 88.06 |
Molecular Formula: | C3H4O3 |
Canonical SMILES: | CC(=O)C(=O)O |
InChI: | InChI=1S/C3H4O3/c1-2(4)3(5)6/h1H3,(H,5,6) |
InChI Key: | LCTONWCANYUPML-UHFFFAOYSA-N |
Boiling Point: | 186.79 °C (EPI 4.0) |
Melting Point: | 11.8°C |
Flash Point: | 82°C |
Purity: | 95.0 % |
Density: | 1.25 g/cm3 |
Solubility: | Soluble in water and alcohol. |
Appearance: | Light yellow liquid |
Storage: | Store tightly sealed under inert gas below 0 deg. C |
MDL: | MFCD00002585 |
LogP: | -0.34000 |
Refractive Index: | 1.423 : 1.433 at 20 deg C |
Stability: | Stable. Combustible. Incompatible with strong oxidizing agents, strong bases. Refrigerate. |
Vapor Pressure: | 1.29 [mmHg] |
GHS Hazard Statement: | H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P264, P280, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113121475-A | Unsaturated fatty acid compound and preparation method and application thereof | 20210330 |
CN-111875662-A | Extraction method and application of clematis midriflora stem chemical extract | 20200819 |
CN-110628839-A | Method for green and efficient preparation of L-selenium methyl selenocysteine | 20191104 |
CN-112300154-A | Nitrogen-containing heterocyclic compound, preparation method and application thereof | 20190731 |
US-10376866-B2 | Method of regeneration of a spent sulfuric acid catalyst from alkylation of olefins and alkanes via paired oxidation | 20170627 |
PMID | Publication Date | Title | Journal |
31704469 | 20200301 | Technical-grade chlordane compromises rat Sertoli cells proliferation, viability and metabolic activity | Toxicology in vitro : an international journal published in association with BIBRA |
31170414 | 20190815 | Non-monotonic dose-response effects of arsenic on glucose metabolism | Toxicology and applied pharmacology |
30448556 | 20190301 | Overexpression of HIF-1a could partially protect K562 cells from 1,4-benzoquinone induced toxicity by inhibiting ROS, apoptosis and enhancing glycolysis | Toxicology in vitro : an international journal published in association with BIBRA |
30115664 | 20181101 | Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance | Molecular cancer therapeutics |
30038219 | 20180901 | Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo | Nature medicine |
Complexity: | 84 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 88.016043985 |
Formal Charge: | 0 |
Heavy Atom Count: | 6 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 88.016043985 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 54.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS